Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
gptkb:2C-C
|
| gptkbp:CASNumber |
3446-89-7
|
| gptkbp:chemicalFormula |
C10H14ClNO2
|
| gptkbp:discoveredBy |
gptkb:Alexander_Shulgin
|
| gptkbp:drugClass |
amphetamine
psychedelic |
| gptkbp:effect |
euphoria
hallucinations visual enhancement altered thinking |
| gptkbp:firstDescribed |
gptkb:PiHKAL
|
| gptkbp:hasSMILES |
CC1=CC(=C(C=C1Cl)OC)OCCN
|
| https://www.w3.org/2000/01/rdf-schema#label |
25C
|
| gptkbp:IUPACName |
2-(4-chloro-2,5-dimethoxyphenyl)ethanamine
|
| gptkbp:legalStatus |
gptkb:Schedule_III_(Canada)
gptkb:Class_A_(UK) Schedule I (USA) |
| gptkbp:mainStreet |
gptkb:2C-C
|
| gptkbp:meltingPoint |
208–210 °C
|
| gptkbp:molecularWeight |
215.68 g/mol
|
| gptkbp:PubChem_CID |
2732912
|
| gptkbp:relatedTo |
gptkb:2C-E
gptkb:2C-B gptkb:2C-I |
| gptkbp:routeOfAdministration |
oral
insufflation sublingual |
| gptkbp:toxicity |
not well studied
|
| gptkbp:UNII |
6Z1Y2V4A7M
|
| gptkbp:bfsParent |
gptkb:New_York_State_Route_25C
|
| gptkbp:bfsLayer |
7
|